TheraBionic is the only FDA-approved therapy indicated in liver cancer patients that fail first-line and second-line therapy, so that's really the place it takes right now in 2025. Patients can ...

Researchers describe successful tumor removal through the use of immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.

Long classified as a subset of common liver cancer, FLC should be considered ... coupled with a just-launched clinical trial of a promising drug treatment, could significantly improve health ...